UBS AM’s DermTech, Inc. Common Stock DMTK Stock Holding History

UBS AM’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-53,872	Closed	-$213K	–	2767
2022 Q3	$213K	Buy	53,872 +8,430	+19%	+$51.8K	﹤0.01%	2587
2022 Q2	$252K	Buy	45,442 +31,542	+227%	+$258K	﹤0.01%	2521
2022 Q1	$204K	Hold	13,900	–	–	﹤0.01%	2675
2021 Q4	$220K	Hold	13,900	–	–	﹤0.01%	2749
2021 Q3	$446K	Sell	13,900 -5,231	-27%	-$184K	﹤0.01%	2541
2021 Q2	$795K	Buy	+19,131	New	+$786K	﹤0.01%	2331

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM's DMTK Position: Q4 2022 in Review

UBS AM sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 53,872 shares — an estimated $213K sold.

UBS AM first reported a position in DMTK in Q2 2021 and held it in 6 quarters. The position peaked at $795K in Q2 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

UBS AM reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
UBS AM sold 53,872 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $213K.
UBS AM first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
UBS AM's DermTech, Inc. Common Stock position peaked at $795K in Q2 2021.
94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.